InnoPlexus

10 statements across 1 episodes · 5 bullish · 0 bearish · 1 people on the record · first statement Feb 24, 2018 by Gunjan Bhardwaj · said 16 times in 1 episodes since 2018 · across every show →

Mentions by year

brought up most by Nathan Latka (14), Gunjan Bhardwaj (2)

mentionsepisodesper episode tap a year for its mentions

2018 16 mentions in 1 episode

945 He's Democratizing Health Data Across Big Pharma With 200 Customers, $3.5m Revenue Feb 24, 2018 · 16 mentions · from 0:52
every mention in 2018, scene by scene →

every mention, scene by scene, with the transcript →

Everything said about InnoPlexus, oldest first

Feb 24, 2018

Disclosure

InnoPlexus charges six figures annually for a ten-user SaaS deployment

“Well, as I mentioned it depends on the number of users for something like 10 users or so, it could the price could go range of six digit dollar figures. Depending on what indication and what therapeutic area they are looking at.”

Gunjan Bhardwaj Feb 24, 2018 ▶ 3:56 945 He's Democratizing Health Data Across Big Pharma With 200 Customers, $3.5m Revenue

Feb 24, 2018

Assertion Not checkable as stated

InnoPlexus reaches team size of around 140 people

“We are around 140 people.”

Gunjan Bhardwaj Feb 24, 2018 ▶ 6:42 945 He's Democratizing Health Data Across Big Pharma With 200 Customers, $3.5m Revenue

Feb 24, 2018 bullish

Assertion Not checkable as stated

InnoPlexus operates at a revenue run rate slightly over €3.5M

“In terms of run rate, we would be slightly above half of that.”

Gunjan Bhardwaj Feb 24, 2018 ▶ 11:48 945 He's Democratizing Health Data Across Big Pharma With 200 Customers, $3.5m Revenue

Feb 24, 2018 bullish

Assertion Not checkable as stated

InnoPlexus reports zero customer churn for its licensed software products

“We haven't lost a single client that has licensed our products.”

Gunjan Bhardwaj Feb 24, 2018 ▶ 12:59 945 He's Democratizing Health Data Across Big Pharma With 200 Customers, $3.5m Revenue

Feb 24, 2018

Disclosure

Bhardwaj: InnoPlexus serves around six major pharmaceutical clients

“So we have around six big pharma clients for various therapeutic areas.”

Gunjan Bhardwaj Feb 24, 2018 ▶ 7:08 945 He's Democratizing Health Data Across Big Pharma With 200 Customers, $3.5m Revenue

Feb 24, 2018 bullish

Assertion Supported

Bhardwaj: InnoPlexus holds 15 patent applications with substantial growth expected

“We have 15 patent applications as we speak, and that number is going to increase next year substantially.”

Gunjan Bhardwaj Feb 24, 2018 ▶ 15:42 945 He's Democratizing Health Data Across Big Pharma With 200 Customers, $3.5m Revenue

Feb 24, 2018 positive

Assertion Not checkable as stated

InnoPlexus replaces Indian and Chinese manual data curation monopolies with AI

“That has been a monopoly of large data service companies manually curating data, hiring thousands of analysts in India and China. We are replacing all of that using AI leveraged algorithms.”

Gunjan Bhardwaj Feb 24, 2018 ▶ 3:00 945 He's Democratizing Health Data Across Big Pharma With 200 Customers, $3.5m Revenue

Feb 24, 2018 bullish

Prediction Not publicly verifiable

Bhardwaj projects InnoPlexus will reach approximately €8M in revenue next year

“We'll do around eight.”

Gunjan Bhardwaj Feb 24, 2018 ▶ 12:05 945 He's Democratizing Health Data Across Big Pharma With 200 Customers, $3.5m Revenue

Feb 24, 2018

Assertion Not publicly verifiable

InnoPlexus raises around $10M in total venture capital

“It was till now including pre-series A, we have raised around ten million dollars.”

Gunjan Bhardwaj Feb 24, 2018 ▶ 5:55 945 He's Democratizing Health Data Across Big Pharma With 200 Customers, $3.5m Revenue

Feb 24, 2018

Assertion Not checkable as stated

InnoPlexus generates 85% of revenue from recurring SaaS

“85%.”

Gunjan Bhardwaj Feb 24, 2018 ▶ 6:36 945 He's Democratizing Health Data Across Big Pharma With 200 Customers, $3.5m Revenue

InnoPlexus

Mentions by year

Everything said about InnoPlexus, oldest first

Turn any episode into a week of clips.